Satellos Bioscience Statistics
Total Valuation
MSCLF has a market cap or net worth of 70.59 million. The enterprise value is 27.49 million.
| Market Cap | 70.59M |
| Enterprise Value | 27.49M |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 176.31M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +22.95% |
| Shares Change (QoQ) | +37.62% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 145.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.43 |
Financial Position
The company has a current ratio of 16.44
| Current Ratio | 16.44 |
| Quick Ratio | 15.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.24% and return on invested capital (ROIC) is -36.67%.
| Return on Equity (ROE) | -61.24% |
| Return on Assets (ROA) | -33.91% |
| Return on Invested Capital (ROIC) | -36.67% |
| Return on Capital Employed (ROCE) | -47.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.29M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MSCLF has paid 63,000 in taxes.
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.67% in the last 52 weeks. The beta is 0.67, so MSCLF's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +4.67% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.52 |
| Relative Strength Index (RSI) | 42.77 |
| Average Volume (20 Days) | 114,297 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -13.77M |
| Operating Income | -19.70M |
| Pretax Income | -20.50M |
| Net Income | -20.56M |
| EBITDA | -19.68M |
| EBIT | -19.70M |
| Earnings Per Share (EPS) | -0.16 |
Balance Sheet
The company has 41.19 million in cash and n/a in debt, giving a net cash position of 41.19 million.
| Cash & Cash Equivalents | 41.19M |
| Total Debt | n/a |
| Net Cash | 41.19M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.67M |
| Book Value Per Share | 0.25 |
| Working Capital | 41.67M |
Cash Flow
In the last 12 months, operating cash flow was -19.22 million and capital expenditures -3,174, giving a free cash flow of -19.22 million.
| Operating Cash Flow | -19.22M |
| Capital Expenditures | -3,174 |
| Free Cash Flow | -19.22M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MSCLF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.95% |
| Shareholder Yield | n/a |
| Earnings Yield | -29.13% |
| FCF Yield | -27.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 18, 2021. It was a reverse split with a ratio of 0.05.
| Last Split Date | Aug 18, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |